Australia - English - Department of Health (Therapeutic Goods Administration)

ausmedic australia pty ltd - 36754 - bath, water - a bath typically designed with a heating element and thermostat which uses water as a heating medium.this is used to raise the temperature of thermoplastics placed in the bath

European Union - English - EMA (European Medicines Agency)

pharmsure veterinary products europe ltd - mycoplasma synoviae strain ms-h - immunologicals for aves, live bacterial vaccines - chicken - for active immunisation of future broiler breeder chickens, future layer breeder chickens and future layer chickens to reduce air sac lesions and reduce the number of eggs with abnormal shell formation caused by mycoplasma synoviae.

Australia - English - Department of Health (Therapeutic Goods Administration)

midmed pty ltd - 33512 - multi-purpose warming cabinet, mobile - designed to warm fluids in bottles or containers, blankets, textiles and other items for medical use that will benefit from being warmed, within the range 25?c - 42?c or 25?c - 70?c depending on the individual model. the warming function is controlled via an electronic thermostat and is intended for continuous operation.

Australia - English - Department of Health (Therapeutic Goods Administration)

chs healthcare pty ltd - 15555 - bath, - the clear and soft shape of this tub reminds of modern, contemporary private bathrooms and perfectly fits in the existing wellness and bathing concept of your bathroom. a special feature of the avero comfort tub are its radii which are reflected both on the inside and on the outside lining. without compromising the beauty of the tub or the aesthetics of your nursing bathroom, this unique tub design enables the tub to be rotated and placed in the room in such a way that the resident can look freely around the room while bathing. this greatly enhances the feeling of wellbeing of the bather.the avero comfort lifting tub stands solidly in the room without fixation and can be freely accessed so that even in constricted spaces and in the narrowest of spaces, all modern care hoists available in the market can be used without any problems, of the manufacturer. the size of the regardless comfortable interior enables the patient to lie down comfortably and to bathe with or without hoist. the specially adapted back shape of the tub body with its prominent arm rests makes for a harmonised interior tub form which allows for ergonomic lying comfort to the patient. a thermostatic mixer of the hans-grohe brand mounted on the tub rim strengthens the homely character of the lifting tub.the modern, elegant and timeless tub shape fits unobtrusively in your new nursing bathroom and at the same time gives your residents, your staff and visitors the impression of a domestic surrounding. premium, chromed brass grips with distinctive design and additional insertions for a tub shortener embedded in the tub rim not only give the tub a distinctive look but also provide excellent hold points for the patient.

United States - English - NLM (National Library of Medicine)

fenwal, inc. - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), sodium acetate (unii: 4550k0sc9b) (acetate ion - unii:569dqm74sc), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, dibasic, unspecified form (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr) - sodium chloride 452 mg in 100 ml - rx only for use with the amicus separator only. store at controlled room temperature. protect from freezing. avoid excessive heat. definition of "controlled room temperature": "a temperature maintained thermostatically that encompasses the usual and customary working environment of 20° to 25°c (68° to 77°f); that results in a mean kinetic temperature calculated to be not more than 25°c; and that allows for excursions between 15°c and 30°c (59° and 86°f) that are experienced in pharmacies, hospitals, and warehouses. provided the mean kinetic temperature remains in the allowed range, transient spikes up to 40°c are permitted as long as they do not exceed 24 hours ... the mean kinetic temperature is a calculated value that may be used as an isothermal storage temperature that simulates the non isothermal effects of storage temperature variations." reference: united states pharmacopeia, general notices. united states pharmacopeial convention, inc. 12601 twinbrook parkway, rockville, md.

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - olanzapine (unii: n7u69t4szr) (olanzapine - unii:n7u69t4szr) - olanzapine 5 mg - oral zyprexa is indicated for the treatment of schizophrenia. efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. in adolescent patients with schizophrenia (ages 13-17), efficacy was established in one 6-week trial [see clinical studies (14.1)] . when deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and hyperlipidemia. clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see warnings and precautions (5.5, 5.6)] . monotherapy — oral zyprexa is indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder and maintenance treatment of bipolar i disorder. efficacy was established in three clinical trials in adult patients with manic or mixed ep

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - olanzapine (unii: n7u69t4szr) (olanzapine - unii:n7u69t4szr) - olanzapine 10 mg - olanzapine tablets are indicated for the treatment of schizophrenia. efficacy was established in three clinical trials in adult patients with schizophrenia: two 6 week trials and one maintenance trial. in adolescent patients with schizophrenia (ages 13 to 17), efficacy was established in one 6 week trial [ see clinical studies (14.1) ]. when deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [ see warnings and precautions ( 5.5 ) ]. olanzapine tablets are indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder and maintenance treatment of bipolar i disorder. efficacy was established in three clinical trials in adult patients with manic or mixed epi

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - olanzapine (unii: n7u69t4szr) (olanzapine - unii:n7u69t4szr) - olanzapine 2.5 mg - olanzapine tablets are indicated for the treatment of schizophrenia. efficacy was established in three clinical trials in adult patients with schizophrenia: two 6 week trials and one maintenance trial. in adolescent patients with schizophrenia (ages 13 to 17), efficacy was established in one 6 week trial [see clinical studies (14.1) ]. when deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see warnings and precautions ( 5.5 ) ]. olanzapine tablets are indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder and maintenance treatment of bipolar i disorder. efficacy was established in three clinical trials in adult patients with manic or mixed episo

United States - English - NLM (National Library of Medicine)

dr reddy's laboratories limited - nizatidine (unii: p41pml4ghr) (nizatidine - unii:p41pml4ghr) - nizatidine 150 mg - nizatidine capsules are indicated for up to 8 weeks for the treatment of active duodenal ulcer. in most patients, the ulcer will heal within 4 weeks. nizatidine capsules are indicated for maintenance therapy for duodenal ulcer patients at a reduced dosage of 150 mg h.s. after healing of an active duodenal ulcer. the consequences of continuous therapy with nizatidine for longer than 1 year are not known. nizatidine capsules are indicated for up to 12 weeks for the treatment of endoscopically diagnosed esophagitis, including erosive and ulcerative esophagitis, and associated heartburn due to gerd. nizatidine capsules are indicated for up to 8 weeks for the treatment of active benign gastric ulcer. before initiating therapy, care should be taken to exclude the possibility of malignant gastric ulceration.

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - olanzapine (unii: n7u69t4szr) (olanzapine - unii:n7u69t4szr) - olanzapine 10 mg - oral zyprexa is indicated for the treatment of schizophrenia. efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. in adolescent patients with schizophrenia (ages 13-17), efficacy was established in one 6-week trial [see clinical studies ( 14.1)] . when deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see warnings and precautions ( 5.5)] . monotherapy — oral zyprexa is indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder and maintenance treatment of bipolar i disorder. efficacy was established in three clinical trials in adult patients with manic or mixed episo